Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-09-06 4:50 pm Purchase | 2022-09-02 | 13D | SOLID BIOSCIENCES INC SLDB | RA Capital Management, L.P. | 829,858 11.010% | 5,333![]() (+0.65%) | Filing History |
| 2022-09-06 4:30 pm Purchase | 2022-08-24 | 13G | COGENT BIOSCIENCES INC COGT | RA Capital Management, L.P. | 3,612,207 5.490% | 3,612,207![]() (New Position) | Filing History |
| 2022-09-02 4:30 pm Purchase | 2022-08-31 | 13D | FORMA THERAPEUTICS HLDGS INC FMTX | RA Capital Management, L.P. | 9,040,309 18.880% | 11,125![]() (+0.12%) | Filing History |
| 2022-08-29 5:01 pm Purchase | 2022-08-25 | 13D | POINT BIOPHARMA GLOBAL INC PNT | RA Capital Management, L.P. | 9,003,018 9.900% | 147,000![]() (+1.66%) | Filing History |
| 2022-08-26 4:38 pm Purchase | 2022-08-16 | 13G | FULCRUM THERAPEUTICS INC FULC | RA Capital Management, L.P. | 7,000,000 13.450% | 7,000,000![]() (New Position) | Filing History |
| 2022-08-15 5:19 pm Sale | 2022-08-15 | 13G | SCPHARMACEUTICALS INC SCPH | RA Capital Management, L.P. | 0 0.000% | -2,691,770![]() (Position Closed) | Filing History |
| 2022-08-15 5:15 pm Sale | 2022-08-15 | 13G | MACROGENICS INC MGNX | RA Capital Management, L.P. | 0 0.000% | -6,103,594![]() (Position Closed) | Filing History |
| 2022-08-15 5:12 pm Sale | 2022-08-15 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | RA Capital Management, L.P. | 0 0.000% | -1,930,322![]() (Position Closed) | Filing History |
| 2022-08-15 5:10 pm Sale | 2022-08-15 | 13G | TSCAN THERAPEUTICS INC TCRX | RA Capital Management, L.P. | 0 0.000% | -1,255,317![]() (Position Closed) | Filing History |
| 2022-08-15 5:06 pm Sale | 2022-08-15 | 13G | CYTEIR THERAPEUTICS INC CYTT | RA Capital Management, L.P. | 0 0.000% | -3,350,506![]() (Position Closed) | Filing History |
| 2022-08-15 5:04 pm Sale | 2022-08-15 | 13G | AKOUOS INC AKUS | RA Capital Management, L.P. | 0 0.000% | -2,281,249![]() (Position Closed) | Filing History |
| 2022-08-15 4:59 pm Sale | 2022-08-15 | 13G | EDGEWISE THERAPEUTICS INC EWTX | RA Capital Management, L.P. | 0 0.000% | -2,613,623![]() (Position Closed) | Filing History |
| 2022-08-12 4:32 pm Sale | 2009-02-28 | 13D | 89BIO INC ETNB | RA Capital Management, L.P. | 4,304,447 14.570% | -3,501,722![]() (-44.86%) | Filing History |
| 2022-07-06 5:25 pm Purchase | 2009-02-28 | 13D | 89BIO INC ETNB | RA Capital Management, L.P. | 7,806,169 19.900% | 3,514,288![]() (+81.88%) | Filing History |
| 2022-06-23 4:49 pm Unchanged | 2022-06-16 | 13D | PEPGEN INC PEPG | RA Capital Management, L.P. | 8,131,952 34.410% | 0 (Unchanged) | Filing History |
| 2022-06-22 4:31 pm Purchase | 2022-06-16 | 13G | INSTIL BIO INC TIL | RA Capital Management, L.P. | 383,540 5.930% | 383,540![]() (New Position) | Filing History |
| 2022-06-21 4:35 pm Purchase | 2009-02-28 | 13D | WAVE LIFE SCIENCES LTD WVE | RA Capital Management, L.P. | 17,269,811 19.990% | 9,441,354![]() (+120.60%) | Filing History |
| 2022-06-03 5:11 pm Sale | 2022-06-02 | 13D | KALA PHARMACEUTICALS INC KALA | RA Capital Management, L.P. | 2,730 4.700% | -2,226![]() (-44.92%) | Filing History |
| 2022-05-31 5:31 pm Sale | 2022-05-26 | 13D | KALA PHARMACEUTICALS INC KALA | RA Capital Management, L.P. | 4,956 8.530% | -1,480![]() (-23.00%) | Filing History |
| 2022-05-25 5:12 pm Sale | 2022-05-23 | 13D | KALA PHARMACEUTICALS INC KALA | RA Capital Management, L.P. | 6,436 11.080% | -2,296![]() (-26.29%) | Filing History |

